Have you ever used a product and thought, “This would be so much better if they had just…”? or “If they had asked me, I would have suggested they…”
SomnoMed, a manufacturer of obstructive sleep apnea (OSA) products, solicited just that kind of feedback from its users—and made changes to what was already a successful product.
The SomnoDent Herbst Advance, the first intraoral device with a visual calibration indicator for OSA treatment, recently underwent some changes, including:
These updates aim to make this FDA-approved product even more comfortable and durable for patients.
However, even before these adjustments, the Herbst Advance boasted a very high satisfaction rate. In fact, 88 percent of patients said the device was comfortable, and 89 percent reported sleeping better at night while using it.
Those figures help make the case that the Herbst Advance can rival the traditional continuous positive airway pressure (CPAP) machine. According to SomnoMed, 40 percent of CPAP patients stop using their CPAP at some point. Meanwhile, nine out of 10 SomnoDent patients report continuing to use their device even after having it for years. Those numbers go a long way when it comes to patient compliance. OSA can be a dangerous—even deadly—medical condition, so compliance with a device that ensures the patient is able to breathe throughout the night is essential.
Not only has the Herbst Advance secured patient and dentist approval, it also has secured the coveted Centers for Medicare and Medicaid Services’ approval. With Medicare approval, the Herbst Advance is a solution available to a larger patient population than many competing products.
Is the Herbst Advance a solution that would benefit your patients? To find out more this device, visit somnomed.com.